2-232756197-CTTTTTT-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001103146.3(GIGYF2):c.268-11_268-6del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00385 in 708,800 control chromosomes in the GnomAD database, including 9 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0035 ( 5 hom., cov: 0)
Exomes 𝑓: 0.0039 ( 4 hom. )
Consequence
GIGYF2
NM_001103146.3 intron
NM_001103146.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.60
Genes affected
GIGYF2 (HGNC:11960): (GRB10 interacting GYF protein 2) This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 2-232756197-CTTTTTT-C is Benign according to our data. Variant chr2-232756197-CTTTTTT-C is described in ClinVar as [Likely_benign]. Clinvar id is 3044764.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00351 (360/102680) while in subpopulation EAS AF= 0.0502 (188/3748). AF 95% confidence interval is 0.0443. There are 5 homozygotes in gnomad4. There are 157 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High AC in GnomAd4 at 360 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GIGYF2 | NM_001103146.3 | c.268-11_268-6del | intron_variant | ENST00000373563.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GIGYF2 | ENST00000373563.9 | c.268-11_268-6del | intron_variant | 1 | NM_001103146.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00350 AC: 360AN: 102714Hom.: 5 Cov.: 0
GnomAD3 genomes
AF:
AC:
360
AN:
102714
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00391 AC: 2368AN: 606120Hom.: 4 AF XY: 0.00375 AC XY: 1206AN XY: 321444
GnomAD4 exome
AF:
AC:
2368
AN:
606120
Hom.:
AF XY:
AC XY:
1206
AN XY:
321444
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00351 AC: 360AN: 102680Hom.: 5 Cov.: 0 AF XY: 0.00330 AC XY: 157AN XY: 47572
GnomAD4 genome
AF:
AC:
360
AN:
102680
Hom.:
Cov.:
0
AF XY:
AC XY:
157
AN XY:
47572
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
GIGYF2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 21, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at